Confidence in the safety of AstraZeneca’s COVID-19 vaccine has had great success in Spain, Germany, France and Italy, as reports of rare blood clots have been linked to it and many countries have briefly ceased the ‘use, according to survey data Monday.
Polling firm YouGov said it had already discovered in late February that Europeans were more hesitant about the AstraZeneca vaccine than those at Pfizer Inc / BioNTech and Moderna Inc, and that concerns about clots had further affected the population. public perceptions of the safety of the AstraZeneca vaccine.
Scientists Still Exploring AstraZeneca COVID-19 Vaccine Link to Blood Clots
At least 13 European countries in the past two weeks have stopped administering the AstraZeneca vaccine, co-developed with scientists at the University of Oxford, after reporting a small number of blood disorders.
The story continues under the ad
Many resumed its use on Friday after the European Medicines Agency regulator said in a preliminary safety review Thursday that the vaccine was safe and effective and was not linked to an increased overall risk of blood clots .
However, the EMA did not rule out a possible link with rare cases of blood clots in the brain known as cerebral venous sinus thrombosis (CVST).
WHO Says AstraZeneca COVID-19 Vaccine ‘Has Huge Potential’ Following Data Review
YouGov’s poll – which covered around 8,000 people in seven European countries between March 12 and March 18 – found that in France, Germany, Spain and Italy, people were now more likely to consider the AstraZeneca vaccine. as dangerous as as safe.
Ontario Reports Nearly 1,800 New Coronavirus Cases, 18 More Deaths
American accused of murder says he really killed 16: prosecutor
Some 55% of Germans say it’s dangerous, while less than a third think it’s safe, according to the poll. In France, where AstraZeneca’s COVID vaccine was already unpopular, 61% of people now say they consider it dangerous.
In Italy and Spain, most people previously thought the AstraZeneca vaccine was safe – at 54% and 59% respectively – but those rates fell to 36% and 38% respectively, in the latest poll.
Does AstraZeneca’s COVID-19 vaccine cause blood clots? Here’s what we know so far
The investigation showed that it was only in Britain, where the AstraZeneca COVID-19 vaccine has been used in a nationwide rollout since January, that blood clot issues have had little or no impact on the public confidence. The majority of people polled in the UK – 77% – still say the hit is safe. Their self-confidence is on par with Pfizer’s perceived safety rating of 79%.
YouGov also said there appeared to be no contagion issues in the seven European countries surveyed for the Pfizer and Moderna COVID-19 vaccines, both of which were considered as safe as in a poll three weeks ago.